Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy
Loss of heterozygosity (LOH) is a common genetic event in the development of cancer. In certain tumor types, LOH can affect more than 20% of the genome, entailing loss of allelic variation in thousands of genes. This reduction of heterozygosity creates genetic differences between tumor and normal ce...
Saved in:
Main Authors: | Xiaonan Zhang (Author), Tobias Sjöblom (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular biology techniques for loss of heterozygosity detection: the glioma example
by: Tiago D. P. Ramos, et al.
Published: (2015) -
Characterization and clinical evaluation of microsatellite instability and loss of heterozygosity within tumor-related genes in colorectal cancer
by: Xueyun Huo, et al.
Published: (2021) -
The Widely Used Antihelmintic Drug Albendazole is a Potent Inducer of Loss of Heterozygosity
by: Luiza S. E. P. Will Castro, et al.
Published: (2021) -
Synchronous thyroid cancer and malignant struma ovarii: concordant mutations and microRNA profile, discordant loss of heterozygosity loci
by: Gabriella T. Seo, et al.
Published: (2023) -
The first case of intellectual disability caused by novel compound heterozygosity for NUDT2 variants
by: Bo Bi, et al.
Published: (2024)